These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies. Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727 [TBL] [Abstract][Full Text] [Related]
25. Current and Emerging Treatment Modalities for Leber's Hereditary Optic Neuropathy: A Review of the Literature. Theodorou-Kanakari A; Karampitianis S; Karageorgou V; Kampourelli E; Kapasakis E; Theodossiadis P; Chatziralli I Adv Ther; 2018 Oct; 35(10):1510-1518. PubMed ID: 30173326 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and Safety of rAAV2-ND4 Treatment for Leber's Hereditary Optic Neuropathy. Wan X; Pei H; Zhao MJ; Yang S; Hu WK; He H; Ma SQ; Zhang G; Dong XY; Chen C; Wang DW; Li B Sci Rep; 2016 Feb; 6():21587. PubMed ID: 26892229 [TBL] [Abstract][Full Text] [Related]
27. Longterm Reversal of Severe Visual Loss by Mitochondrial Gene Transfer in a Mouse Model of Leber Hereditary Optic Neuropathy. Yu H; Porciatti V; Lewin A; Hauswirth W; Guy J Sci Rep; 2018 Apr; 8(1):5587. PubMed ID: 29615737 [TBL] [Abstract][Full Text] [Related]
28. Reply: Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion. Yu-Wai-Man P; Hudson G; Klopstock T; Chinnery PF Brain; 2016 Mar; 139(Pt 3):e18. PubMed ID: 26657167 [No Abstract] [Full Text] [Related]
29. Gene-Based Therapies for Leber Hereditary Optic Neuropathy. Hype or Hope? Mackey DA; Kearns LS; Hewitt AW Asia Pac J Ophthalmol (Phila); 2016; 5(4):253-5. PubMed ID: 27488066 [TBL] [Abstract][Full Text] [Related]
30. Co-existence of m.10663T>C Mutation with Haplogroup L3f1b Background in a Patient with LHON. Al-Kharashi M; Al-Kharashi A; Al-Obailan M; Kondkar AA; Abu-Amero KK Can J Neurol Sci; 2016 Mar; 43(2):332-3. PubMed ID: 26750644 [No Abstract] [Full Text] [Related]
31. Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy. Wong RCB; Lim SY; Hung SSC; Jackson S; Khan S; Van Bergen NJ; De Smit E; Liang HH; Kearns LS; Clarke L; Mackey DA; Hewitt AW; Trounce IA; Pébay A Aging (Albany NY); 2017 Apr; 9(4):1341-1350. PubMed ID: 28455970 [TBL] [Abstract][Full Text] [Related]
32. LHON/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation. Blakely EL; de Silva R; King A; Schwarzer V; Harrower T; Dawidek G; Turnbull DM; Taylor RW Eur J Hum Genet; 2005 May; 13(5):623-7. PubMed ID: 15657614 [TBL] [Abstract][Full Text] [Related]
34. m.3635G>A mutation as a cause of Leber hereditary optic neuropathy. Kodroń A; Krawczyński MR; Tońska K; Bartnik E J Clin Pathol; 2014 Jul; 67(7):639-41. PubMed ID: 24747208 [TBL] [Abstract][Full Text] [Related]
35. A double mutation (G11778A and G12192A) in mitochondrial DNA associated with Leber's hereditary optic neuropathy and cardiomyopathy. Mimaki M; Ikota A; Sato A; Komaki H; Akanuma J; Nonaka I; Goto Y J Hum Genet; 2003; 48(1):47-50. PubMed ID: 12560876 [TBL] [Abstract][Full Text] [Related]
36. Leber's hereditary optic neuropathy: clinical and molecular genetic results in a patient with a point mutation at np T11253C (isoleucine to threonine) in the ND4 gene and spontaneous recovery. Leo-Kottler B; Luberichs J; Besch D; Christ-Adler M; Fauser S Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):758-64. PubMed ID: 12271374 [TBL] [Abstract][Full Text] [Related]
37. Early identification of LHON carriers may improve outcome. Finsterer J Rom J Ophthalmol; 2019; 63(1):102-103. PubMed ID: 31198904 [No Abstract] [Full Text] [Related]
38. SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I. Qi X; Lewin AS; Sun L; Hauswirth WW; Guy J Ann Neurol; 2004 Aug; 56(2):182-91. PubMed ID: 15293270 [TBL] [Abstract][Full Text] [Related]